Literature DB >> 12102550

Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules.

Andrei I Chapoval1, Gefeng Zhu, Lieping Chen.   

Abstract

Costimulatory signal(s) in addition to engagement of T cell receptor is important for optimal activation of T lymphocytes. During last decade several dozens of new costimulatory molecules, including 4-1BB, CD40, OX40, CD27, and ICOS, have been identified. It is likely that in Post-Genome Era more molecules with potential costimulatory properties will be brought to our attention. We describe here a simple and reliable strategy for evaluating the functional activities of potential costimulatory molecules using soluble fusion protein between extracellular portion of costimulatory ligand and Fc portion of mouse IgG2a.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12102550     DOI: 10.1385/MB:21:3:259

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  11 in total

Review 1.  Immunological ignorance of silent antigens as an explanation of tumor evasion.

Authors:  L Chen
Journal:  Immunol Today       Date:  1998-01

2.  Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation.

Authors:  J Curtsinger; M J Deeths; P Pease; M F Mescher
Journal:  J Immunol Methods       Date:  1997-11-10       Impact factor: 2.303

3.  Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma.

Authors:  T Tatsumi; T Takehara; K Katayama; K Mochizuki; M Yamamoto; T Kanto; Y Sasaki; A Kasahara; N Hayashi
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

4.  Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.

Authors:  M Moro; A M Gasparri; S Pagano; M Bellone; P Tornaghi; F Veglia; A Corti; G Casorati; P Dellabona
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

5.  Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies.

Authors:  Y J Guo; X Y Che; F Shen; T P Xie; J Ma; X N Wang; S G Wu; D D Anthony; M C Wu
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

Review 6.  Costimulation of T cells for tumor immunity.

Authors:  L Chen; P S Linsley; K E Hellström
Journal:  Immunol Today       Date:  1993-10

7.  Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells.

Authors:  Y Guo; M Wu; H Chen; X Wang; G Liu; G Li; J Ma; M S Sy
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

8.  New goals for the U.S. Human Genome Project: 1998-2003.

Authors:  F S Collins; A Patrinos; E Jordan; A Chakravarti; R Gesteland; L Walters
Journal:  Science       Date:  1998-10-23       Impact factor: 47.728

Review 9.  Costimulation and its role in organ transplantation.

Authors:  J A Bluestone
Journal:  Clin Transplant       Date:  1996-02       Impact factor: 2.863

10.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Authors:  D J Lenschow; S C Ho; H Sattar; L Rhee; G Gray; N Nabavi; K C Herold; J A Bluestone
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  6 in total

1.  B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.

Authors:  Jang-June Park; Ryusuke Omiya; Yumiko Matsumura; Yukimi Sakoda; Atsuo Kuramasu; Mathew M Augustine; Sheng Yao; Fumihiko Tsushima; Hidehiko Narazaki; Sudarshan Anand; Yingjia Liu; Scott E Strome; Lieping Chen; Koji Tamada
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

2.  B7-H1 agonists could prevent disseminated inflammation by desensitizing cell susceptibility to cytotoxic T-cells.

Authors:  Weiwei Yu; Ling Chen; Sizheng Guo; Liqun Luo; Lieping Chen
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110

3.  Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.

Authors:  Yukimi Sakoda; Jang-June Park; Yuming Zhao; Atsuo Kuramasu; Degui Geng; Yingjia Liu; Eduardo Davila; Koji Tamada
Journal:  Blood       Date:  2011-01-10       Impact factor: 22.113

4.  Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivity.

Authors:  Ryusuke Omiya; Fumihiko Tsushima; Hidehiko Narazaki; Yukimi Sakoda; Atsuo Kuramasu; Youn Kim; Haiying Xu; Hideto Tamura; Gefeng Zhu; Lieping Chen; Koji Tamada
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

5.  Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data.

Authors:  Takeshi Azuma; Gefeng Zhu; Haiying Xu; A Cecilia Rietz; Charles G Drake; Eric L Matteson; Lieping Chen
Journal:  PLoS Med       Date:  2009-10-20       Impact factor: 11.069

6.  A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis.

Authors:  Han Sun; Liqun Luo; Bachchu Lal; Xinrong Ma; Lieping Chen; Christine L Hann; Amy M Fulton; Daniel J Leahy; John Laterra; Min Li
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.